In addition to identifying molecular signatures able to discriminate between regenerative, dysplastic, and malignant nodules as well as confirming the upregulation of HSP70, GPC3, and several other putative tumor markers in early HCC, these investigators performed a comparative functional analysis of DN and HCCs gene expression signatures. This evidence concerns the gene GPC3 and hepatocellular carcinoma.